SCHEMBL6782186

SCHEMBL6782186

Cn1ncc2[nH]c3cccc(-c4ccc(O)cc4)c3c(=O)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 2/20 0.38
CCND1 P24385 2/20 0.38
RET P07949 1/20 0.36
MET P08581 1/20 0.35
MAPK1 P28482 1/20 0.33
MAP2K4 P45985 1/20 0.33
MAPKAPK2 P49137 1/20 0.33
MAPK6 Q16659 1/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
HIF1A Q16665 2/20 0.33
CHEK1 O14757 2/20 0.32
WEE1 P30291 2/20 0.32
ABL1 P00519 1/20 0.32
BCR P11274 1/20 0.32
KIT P10721 1/20 0.32
KDR P35968 1/20 0.32
FLT3 P36888 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784847 0.88 CDK4 (0.39) CDK4CCND1RETMGAMGAA
SCHEMBL6784727 0.88 KDR (0.43) RETMETHIF1ACHEK1ABL1
Hydrochloric Acid SCHEMBL6785628 0.87 KDR (0.42) RETMETHIF1ACHEK1ABL1
SCHEMBL6788209 0.86 PARP1 (0.42) GAAHIF1APARP1
SCHEMBL6784780 0.79 PRMT5 (0.44) GAACHEK1WEE1KDRCLK4
SCHEMBL6788043 0.77 FEN1 (0.42) CDK4CCND1RETGAACHEK1
SCHEMBL6785738 0.76 POLB (0.39) MAPK1GAA
SCHEMBL6781822 0.74 DAO (0.34) GAAHIF1APARP1
SCHEMBL6782703 0.72 KIF11 (0.43) CDK4CCND1GAACHEK1WEE1
SCHEMBL6781518 0.70 FEN1 (0.45) CDK4CCND1MAPK1GAAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG CDK4 1267/4885CCND1 1653/4885RET 1492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.